UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
Energy Recovery
ERII
$394M
| $940K | ﹤0.01% |
96,015
+8,852
| +10% | +$81.6K |
|
|
HNGR
4277
DELISTED
Hanger Inc.
HNGR
| $940K | ﹤0.01% |
34,054
+572
| +2% | +$13.6K |
|
|
AHT
4278
Ashford Hospitality Trust
AHT
$20.3M
| $939K | ﹤0.01% |
336
-51
| -13% | -$143K |
|
4279
ANI Pharmaceuticals
ANIP
$1.71B
| $937K | ﹤0.01% |
15,195
+5,521
| +57% | +$366K |
|
|
CXH
4280
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $936K | ﹤0.01% |
95,825
+65,372
| +215% | +$641K |
|
4281
Nuveen Real Estate Income Fund
JRS
$241M
| $936K | ﹤0.01% |
88,164
+59,165
| +204% | +$632K |
|
|
NRO
4282
Neuberger Real Estate Securities Income Fund Inc
NRO
$187M
| $936K | ﹤0.01% |
175,849
+10,738
| +7% | +$57.5K |
|
|
MOBL
4283
DELISTED
MobileIron, Inc.
MOBL
| $936K | ﹤0.01% |
192,655
+42,984
| +29% | +$229K |
|
|
ATSG
4284
DELISTED
Air Transport Services Group
ATSG
| $935K | ﹤0.01% |
39,845
+14,559
| +58% | +$326K |
|
4285
Cue Biopharma
CUE
$119M
| $933K | ﹤0.01% |
1,961
+344
| +21% | +$108K |
|
4286
Global X S&P 500 Catholic Values ETF
CATH
$1.35B
| $932K | ﹤0.01% |
23,648
-1,757
| -7% | -$66.5K |
|
4287
Pixelworks
PXLW
$38.3M
| $931K | ﹤0.01% |
19,787
+1,201
| +6% | +$49.2K |
|
|
JHMH
4288
DELISTED
John Hancock Multifactor Healthcare ETF
JHMH
| $931K | ﹤0.01% |
25,005
+1,461
| +6% | +$51.4K |
|
4289
Stoneridge
SRI
$193M
| $926K | ﹤0.01% |
31,592
+11,010
| +53% | +$339K |
|
4290
Origin Bancorp
OBK
$1.66B
| $925K | ﹤0.01% |
24,444
+8,933
| +58% | +$313K |
|
4291
TechTarget
TTGT
$271M
| $924K | ﹤0.01% |
35,403
+10,984
| +45% | +$279K |
|
|
BSJP
4292
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $923K | ﹤0.01% |
37,216
+6,176
| +20% | +$151K |
|
|
IDE
4293
Voya Infrastructure, Industrials and Materials Fund
IDE
$200M
| $922K | ﹤0.01% |
80,125
+6,750
| +9% | +$76.3K |
|
4294
Inspire Medical Systems
INSP
$1.71B
| $922K | ﹤0.01% |
12,428
+747
| +6% | +$48K |
|
4295
The RMR Group
RMR
$337M
| $922K | ﹤0.01% |
20,203
+7,598
| +60% | +$353K |
|
4296
Hawkins
HWKN
$2.71B
| $921K | ﹤0.01% |
40,184
+6,342
| +19% | +$134K |
|
4297
Adicet Bio
ACET
$77M
| $918K | ﹤0.01% |
5,500
+5,433
| +8,109% | +$2.75M |
|
|
QVCGA
4298
DELISTED
QVC Group Inc Series A
QVCGA
| $918K | ﹤0.01% |
2,243
-5,066
| -69% | -$2.28M |
|
4299
CALL
Ally Financial
ALLY
$13.4B
| $917K | ﹤0.01% |
+30,000
| New | +$937K |
|
|
RARX
4300
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $917K | ﹤0.01% |
19,532
-92,349
| -83% | -$4.08M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.